A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients

Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection

(2021) Jia-Tsrong Jan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19

(2021) Eduardo López-Medina et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing

(2021) Charlotte Kern et al.   Frontiers in Pharmacology

A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool

(2020)   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency

(2020) Carlos Chaccour et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses

(2020) Mike Bray et al.   ANTIVIRAL RESEARCH

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

(2020) Leon Caly et al.   ANTIVIRAL RESEARCH

Moxidectin: an oral treatment for human onchocerciasis

(2020) Philip Milton et al.   Expert Review of Anti-Infective Therapy

Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen

(2020) Fatemeh Heidary et al.   JOURNAL OF ANTIBIOTICS

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

(2020) Markus Hoffmann et al.   NATURE

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations

(2020) Eloise Baudou et al.   NEW ENGLAND JOURNAL OF MEDICINE

Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships

(2020) Barry M. Popkin et al.   Obesity Reviews

Why COVID-19 is more deadly in people with obesity—even if they're young

(2020) Meredith Wadman   SCIENCE

Why obesity worsens COVID-19

(2020) Meredith Wadman   SCIENCE

Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children

(2020) Amanda Gwee et al.   PLoS Neglected Tropical Diseases

COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort study

(2020) Luigi Di Filippo et al.   CLINICAL NUTRITION

Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2–12 years

(2019) Jessica D Schulz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Safety of high-dose ivermectin: a systematic review and meta-analysis

(2019) Miriam Navarro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dynamics of the double burden of malnutrition and the changing nutrition reality

(2019) Barry M Popkin et al.   LANCET

Serious Neurological Adverse Events after Ivermectin—Do They Occur beyond the Indication of Onchocerciasis?

(2018) Rebecca E. Chandler   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers

(2018) Jose Muñoz et al.   PLoS Neglected Tropical Diseases

Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers

(2018) Urs Duthaler et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Scabies in an obese patient: How should the ivermectin dosing be adapted?

(2018) G. Mellon et al.   MEDECINE ET MALADIES INFECTIEUSES

Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model

(2016) Charlotte Bernigaud et al.   PLoS Neglected Tropical Diseases

Drug Disposition in Obesity: Toward Evidence-Based Dosing

(2015) Catherijne A.J. Knibbe et al.   Annual Review of Pharmacology and Toxicology

Translational value of animal models of obesity—Focus on dogs and cats

(2015) Melania Osto et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Covariate selection in pharmacometric analyses: a review of methods

(2014) Matthew M. Hutmacher et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Relative Neurotoxicity of Ivermectin and Moxidectin in Mdr1ab (−/−) Mice and Effects on Mammalian GABA(A) Channel Activity

(2012) Cécile Ménez et al.   PLoS Neglected Tropical Diseases

Moxidectin and the avermectins: Consanguinity but not identity

(2012) Roger Prichard et al.   International Journal for Parasitology-Drugs and Drug Resistance

Elimination of human onchocerciasis: History of progress and current feasibility using ivermectin (Mectizan®) monotherapy

(2010) E.W. Cupp et al.   ACTA TROPICA

The relationship between BMI and percent body fat, measured by bioelectrical impedance, in a large adult sample is curvilinear and influenced by age and sex

(2010) S. Meeuwsen et al.   CLINICAL NUTRITION

Effect of Obesity on the Pharmacokinetics of Drugs in Humans

(2010) Michael J. Hanley et al.   CLINICAL PHARMACOKINETICS

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

(2009) Radojka M. Savic et al.   AAPS Journal

Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System Pharmacotherapy

(2008) D. S. Miller et al.   PHARMACOLOGICAL REVIEWS

N-in-1 Dosing Pharmacokinetics in Drug Discovery: Experience, Theoretical and Practical Considerations

(2007) Kan He et al.   JOURNAL OF PHARMACEUTICAL SCIENCES